[HTML][HTML] Clinical manifestations, diagnosis, and treatment of sarcoidosis

P Ungprasert, JH Ryu, EL Matteson - Mayo Clinic Proceedings: Innovations …, 2019 - Elsevier
The focus of this review is current knowledge about the epidemiology, clinical
manifestations, diagnosis, and treatment of both pulmonary sarcoidosis and extrapulmonary …

[HTML][HTML] Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for uveitis (FOCUS) initiative

AD Dick, JT Rosenbaum, HA Al-Dhibi, R Belfort Jr… - Ophthalmology, 2018 - Elsevier
Topic An international, expert-led consensus initiative to develop systematic, evidence-
based recommendations for the treatment of noninfectious uveitis in the era of biologics …

Methotrexate for ocular inflammatory diseases

S Gangaputra, CW Newcomb, TL Liesegang… - Ophthalmology, 2009 - Elsevier
PURPOSE: To evaluate the outcome of treatment with methotrexate for noninfectious ocular
inflammation. DESIGN: Retrospective cohort study. PARTICIPANTS: Patients with …

Visual loss in uveitis of childhood

J De Boer, N Wulffraat, A Rothova - British Journal of Ophthalmology, 2003 - bjo.bmj.com
Aims: To investigate the manifestations and severity of uveitis in children and to identify the
risk and specific causes of blindness in this population. Methods: Retrospective study of data …

Uveitis: a potentially blinding disease

OM Durrani, CA Meads, PI Murray - Ophthalmologica, 2004 - karger.com
Uveitis (intraocular inflammation) is a potentially blinding group of, probably autoimmune,
conditions predominantly occurring in the working age group. Although the aetiology is …

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting

G Ferrara, G Mastrangelo, P Barone, F La Torre… - Pediatric …, 2018 - Springer
Background Conventional pharmacological therapies for the treatment of juvenile idiopathic
arthritis (JIA) consist of non-biological, disease-modifying antirheumatic drugs, among which …

A randomized, placebo‐controlled, double‐masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis

JA Smith, DJS Thompson, SM Whitcup… - Arthritis Care & …, 2005 - Wiley Online Library
Objective To investigate the safety and efficacy of etanercept in the treatment of uveitis
associated with juvenile idiopathic arthritis (JIA). Methods Children who met the American …

Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation

A Galor, DA Jabs, HA Leder, SR Kedhar, JP Dunn… - Ophthalmology, 2008 - Elsevier
PURPOSE: To compare the relative effectiveness and side effect profiles of antimetabolite
drugs in the treatment of noninfectious ocular inflammation. DESIGN: Retrospective cohort …

Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis

A Heiligenhaus, H Michels, C Schumacher… - Rheumatology …, 2012 - Springer
Uveitis in juvenile idiopathic arthritis (JIA) is frequently associated with the development of
complications and visual loss. Topical corticosteroids are the first-choice therapy, and …

Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial

RP Baughman, EE Lower, DA Bradley, LA Raymond… - Chest, 2005 - Elsevier
Purpose Study a tumor necrosis factor receptor antagonist (etanercept) in the treatment of
chronic ocular sarcoidosis Subjects and methods Eighteen patients with ocular sarcoidosis …